LPCN
Lipocine Inc

14,451
Mkt Cap
$13.71M
Volume
23,924.00
52W High
$6.16
52W Low
$2.52
PE Ratio
-3.00
LPCN Fundamentals
Price
$2.53
Prev Close
$2.65
Open
$2.57
50D MA
$2.92
Beta
0.70
Avg. Volume
57,667.52
EPS (Annual)
-$0.0016
P/B
0.79
Rev/Employee
$699,884.00
Loading...
Loading...
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
16

Frequently Asked Questions

What is Market Cap of Lipocine Inc?
What is the 52-week high for Lipocine Inc?
What is the 52-week low for Lipocine Inc?
What is Lipocine Inc stock price today?
What was Lipocine Inc stock price yesterday?
What is the PE ratio of Lipocine Inc?
What is the Price-to-Book ratio of Lipocine Inc?
What is the 50-day moving average of Lipocine Inc?
How many employess does Lipocine Inc has?

Latest LPCN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.